Brett DiNatale

Brett DiNatale has extensive experience in assessing pharmaceutical markets from the
perspectives of patients, payers, and health care providers. Working in numerous start-up and
established firms, Brett has performed patient flow analyses and market research, analysis and
forecasting across various therapeutic areas. Qualitative and quantitative work has informed
product launch and legacy brand renewal, R&D resource allocation and go/no-go pipeline
decisions, and global dissemination of physician-targeting information.

Brett holds a BS in biochemistry from Boston College and a PhD in Molecular Medicine from
The Pennsylvania State University. His doctoral research focused on understanding novel
pathways of tumor progression and the design of therapies to combat cancer and autoimmune
diseases. He has been published in numerous peer reviewed journals and has presented at
international scientific conferences.